Mani, Inc. (7730.T) Bundle
Who's quietly steering Mani, Inc. (7730.T)? Institutional heavyweights show a cautious yet notable presence: First Sentier Investors (UK) IM Ltd. - 1.31% (11 Nov 2024), Nikko Asset Management Co., Ltd. - 1.19% (31 Jan 2025), Daiwa Asset Management Co. Ltd. - 1.06% (30 Apr 2025) and BlackRock Fund Advisors - 1.02% (5 Jun 2025), while the company's ownership structure-¥139.97 billion market cap (12 Dec 2025), 98.50 million shares outstanding, 10.15% insider ownership, 27.97% institutional holdings and 61.88% public float-paints a picture of diversified, moderately institutionalized backing; juxtapose that with a closing share price of ¥1,421.00 (12 Dec 2025), a trailing P/E of 30.15 and split analyst views (CLSA's Buy with a ¥2,655 target on 29 Jan 2025 vs. Nomura's Hold at ¥1,200 on 18 Jul 2025) to understand why investors are selectively buying and what that could mean for Mani's next moves-read on to unpack who's influencing governance, valuation and market sentiment.
Mani, Inc. (7730.T) - Who Invests in Mani, Inc. (7730.T) and Why?
Mani, Inc. (7730.T) attracts mostly institutional investors taking relatively small, cautious positions. Major registered holdings reported in public filings between late 2024 and mid-2025 show measured exposure rather than large conviction stakes, consistent with a risk-aware approach among asset managers in the medical instruments sector.| Institution | Stake (%) | Reference Date | Interpretation |
|---|---|---|---|
| First Sentier Investors (UK) IM Ltd. | 1.31% | Nov 11, 2024 | Cautious investment approach; small position size relative to portfolio norms. |
| Nikko Asset Management Co., Ltd. | 1.19% | Jan 31, 2025 | Conservative allocation within regional/global equity holdings. |
| Daiwa Asset Management Co. Ltd. | 1.06% | Apr 30, 2025 | Measured exposure consistent with risk-management frameworks. |
| BlackRock Fund Advisors | 1.02% | Jun 05, 2025 | Prudent index/active blend positioning; small weight in large funds. |
- Profile of investors: institutional asset managers and global funds with diversified mandates.
- Position sizing: stakes in the ~1.0-1.3% range, indicating limited single-stock concentration.
- Timing: holdings reported across a 7-8 month span (Nov 2024-Jun 2025), showing persistent but restrained interest.
- Exposure to medical instruments and dental consumables - niche, resilient demand drivers.
- Stable revenue streams from recurring product lines (consumables, disposables), useful for conservative allocations.
- Valuation and dividend/yield profile that may fit low- to moderate-risk sleeves within multi-asset portfolios.
- Geographic diversification: access to a Japanese medical-equipment name for global funds.
- Company-specific risks: product-cycle concentration, regulatory risk, and competitive pressures in med-tech.
- Market volatility and macro uncertainty impacting export-driven Japanese small/ mid-cap names.
- Smaller free-float liquidity relative to larger industry peers, limiting large-scale position builds.
| Metric | Implication for Investors |
|---|---|
| Stake sizes (~1.0-1.31%) | Indicative of tactical or modest strategic exposure rather than control or activist intent. |
| Holding dates (Nov 2024-Jun 2025) | Consistent, not speculative-positions maintained across reporting periods. |
| Industry peers' typical stakes | Often larger for global leaders; Mani's smaller relative stakes suggest preference for more stable large-cap med-tech by some managers. |
Mani, Inc. (7730.T) - Institutional Ownership and Major Shareholders of Mani, Inc. (7730.T)
Mani, Inc. (7730.T) presents a diversified shareholder structure as of June 10, 2025, with a market capitalization of approximately ¥139.68 billion and 98.50 million shares outstanding. Insider ownership sits at 10.15%, institutional investors hold 27.97%, and public shareholders account for 61.88% of the float - a mix that signals balanced investor confidence and wide retail participation.- Market capitalization: ¥139.68 billion (as of 2025-06-10)
- Shares outstanding: 98.50 million
- Insider ownership: 10.15% - indicates moderate insider alignment with shareholder interests
- Institutional ownership: 27.97% - moderate institutional interest relative to industry norms
- Public/free float: 61.88% - relatively high public ownership supporting liquidity
| Metric | Value |
|---|---|
| Market capitalization | ¥139.68 billion |
| Shares outstanding | 98.50 million |
| Insider ownership | 10.15% |
| Institutional ownership | 27.97% |
| Public ownership (free float) | 61.88% |
- Implications for governance: Insider stake (10.15%) provides meaningful voting alignment but not control; institutional presence (27.97%) brings professional oversight without dominating board influence.
- Liquidity and trading dynamics: High public ownership (61.88%) supports active retail trading and deeper on-exchange liquidity.
- Comparative positioning: Institutional ownership is moderate versus peers, reflecting balanced external confidence rather than concentrated institutional endorsement.
Key Investors and Their Impact on Mani, Inc. (7730.T)
This chapter profiles the principal institutional holders of Mani, Inc. (7730.T), quantifies their shareholdings and outlines the plausible governance, strategic and market impacts stemming from their positions.
| Investor | Reported Stake | Reporting Date | Primary Areas of Influence |
|---|---|---|---|
| First Sentier Investors (UK) IM Ltd. | 1.31% | Nov 11, 2024 | Strategic guidance, board engagement, long-term governance |
| Nikko Asset Management Co., Ltd. | 1.19% | Jan 31, 2025 | Shareholder engagement, policy influence, ESG dialogue |
| Daiwa Asset Management Co. Ltd. | 1.06% | Apr 30, 2025 | Financial strategy input, performance monitoring, capital allocation views |
| BlackRock Fund Advisors | 1.02% | Jun 05, 2025 | Market signaling, investor relations pressure, proxy voting clout |
| Combined (top 4 institutions) | 4.58% | As of latest individual reporting dates | Collective governance influence; credibility boost to Mani, Inc. |
- Concentration: The four named institutions together hold 4.58% of outstanding equity-material for a mid-cap Japanese stock and sufficient to coordinate on governance matters if aligned.
- Timeframe: Stakes range from Nov 2024 to Jun 2025, indicating ongoing institutional interest through multiple reporting cycles.
- Investor types: Mixture of active managers (First Sentier, Nikko, Daiwa) and a large passive/active allocator (BlackRock), creating a balance between long-term stewardship and market-facing influence.
Specific impacts each investor is likely to have:
- First Sentier Investors - pushes for sustainable long-term strategy adjustments, may seek board dialogue on capital allocation and R&D prioritization.
- Nikko Asset Management - engages on corporate policies, ESG integration and operational transparency through stewardship channels.
- Daiwa Asset Management - scrutinizes quarterly/annual performance, may influence financial strategy such as dividend policy or buybacks.
- BlackRock Fund Advisors - amplifies market perception; even a ~1% holding from a global manager can affect liquidity and analyst attention.
Broader effects on Mani, Inc. (7730.T):
- Improved credibility with other institutional and retail investors due to endorsement by well-known asset managers.
- Potential for coordinated engagement on governance, driving changes in transparency, capital allocation or ESG reporting.
- Enhanced market visibility that can lower cost of capital and attract additional institutional flows if performance aligns with expectations.
For additional context on Mani, Inc.'s ownership history and how the business operates, see: Mani, Inc.: History, Ownership, Mission, How It Works & Makes Money
Mani, Inc. (7730.T) - Market Impact and Investor Sentiment
Mani, Inc.'s stock price closed at ¥1,421.00 on December 12, 2025, up 0.28% from the prior trading day. The company's market capitalization stood at ¥139.97 billion, with a trailing P/E ratio of 30.15, signaling a moderate valuation relative to historical norms and peers. Recent analyst activity has been mixed: CLSA maintained a 'Buy' rating and raised its price target to ¥2,655 on January 29, 2025, while Nomura reiterated a 'Hold' rating with a ¥1,200 price target on July 18, 2025. These divergent views underpin a divided investor sentiment that balances optimism about growth and valuation upside with caution tied to near-term performance and market conditions.- Short-term price action: modest intraday volatility with steady trading volumes around key corporate announcements.
- Analyst influence: upward revision from CLSA supports bullish flows; Nomura's hold dampens conviction for risk-averse investors.
- Valuation context: trailing P/E of 30.15 suggests expectations of continued earnings growth; some investors view this as premium.
- Market-cap scale: ¥139.97 billion places Mani in a mid-cap range within the TSE, attracting both domestic institutional and selective international investors.
| Metric | Value | Reference Date |
|---|---|---|
| Closing Price | ¥1,421.00 | Dec 12, 2025 |
| Daily Change | +0.28% | Dec 12, 2025 |
| Market Capitalization | ¥139.97 billion | Dec 12, 2025 |
| Trailing P/E | 30.15 | TTM |
| CLSA Rating / PT | Buy / ¥2,655 | Jan 29, 2025 |
| Nomura Rating / PT | Hold / ¥1,200 | Jul 18, 2025 |
- Key sentiment drivers: earnings trajectory, margin trends, product-cycle updates, and global healthcare demand.
- Investor composition: domestic institutions, selective international funds, and retail investors reacting to analyst notes.
Mani, Inc. (7730.T) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.